XML 21 R6.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY - USD ($)
$ in Thousands
Series B Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Beginning Balance - Shares at Dec. 31, 2014 1,665 20,650        
Beginning Balance - Amount at Dec. 31, 2014 $ 2 $ 21 $ 87,080 $ (87,113) $ (2,962) $ (2,972)
Options exercised & stock-based compensation, Shares   146        
Options exercised & stock-based compensation, Amount     981     981
Shares issued to consultants and other services, Shares   50        
Shares issued to consultants and other services, Amount     204     204
Issuance and exercise of warrants, Shares   270        
Issuance and exercise of warrants, Amount   $ 1 1,098     1,099
Conversion of Series B preferred to common stock, Shares (267) 26        
Conversion of Series B preferred to common stock, Amount $ (1)         (1)
Repurchase of common stock, Shares   (1,600)        
Repurchase of common stock, Amount   $ (3) (7,476)     (7,479)
Issuance of shares for Interest and additional consideration, Shares   77        
Issuance of shares for Interest and additional consideration, Amount   $ 1 228     229
Other comprehensive loss         (217) (217)
Net income (loss)       (27,138)   (27,138)
Ending Balance, Shares at Dec. 31, 2015 1,398 19,619        
Ending Balance, Amount at Dec. 31, 2015 $ 1 $ 20 82,115 (114,251) (3,179) (35,294)
Issuance and exercise of warrants, Shares   232        
Issuance and exercise of warrants, Amount     579     579
Conversion of Series B preferred to common stock, Shares (70) 7        
Stock-based compensation     747     747
Other comprehensive loss         (209) (209)
Net income (loss)       (15,636)   (15,636)
Ending Balance, Shares at Dec. 31, 2016 1,328 19,858        
Ending Balance, Amount at Dec. 31, 2016 $ 1 $ 20 $ 83,441 $ (129,887) $ (3,388) $ (49,813)